Compugen (NASDAQ:CGEN) initiated with Overweight rating and $10 (73% upside) price target at Cantor Fitzgerald. Shares up 3% premarket.
Diplomat Pharmacy (NYSE:DPLO) downgraded to Underperform at Credit Suisse.
GlaxoSmithKline (NYSE:GSK) downgraded to Underweight with a 1,650 pence (9% downside risk) price target at Barclays citing the absence of growth catalysts. Shares down 1% premarket in U.S.
Try Seeking Alpha PREMIUM for unlimited analysis on CGEN